











Sukumar, Nithya, Adaikalakoteswari, Antonysunil, Venkataraman, Hema, Maheswaran, 
Hendramoorthy and Saravanan, Ponnusamy. (2016) Vitamin B12 status in women of 
childbearing age in the UK and its relationship with national nutrient intake guidelines : 
results from two National Diet and Nutrition Surveys. BMJ Open, 6 (8). e011247. 
 
Permanent WRAP URL: 
http://wrap.warwick.ac.uk/82170       
       
Copyright and reuse: 
The Warwick Research Archive Portal (WRAP) makes this work of researchers of the 
University of Warwick available open access under the following conditions. 
 
This article is made available under the Creative Commons Attribution 4.0 International 
license (CC BY 4.0) and may be reused according to the conditions of the license.  For more 
details see: http://creativecommons.org/licenses/by/4.0/   
 
A note on versions: 
The version presented in WRAP is the published version, or, version of record, and may be 
cited as it appears here. 
 
For more information, please contact the WRAP Team at: wrap@warwick.ac.uk 
 
Vitamin B12 status in women of
childbearing age in the UK and its
relationship with national nutrient
intake guidelines: results from two
National Diet and Nutrition Surveys
Nithya Sukumar,1,2 Antonysunil Adaikalakoteswari,1 Hema Venkataraman,1,2
Hendramoorthy Maheswaran,1 Ponnusamy Saravanan1,2
To cite: Sukumar N,
Adaikalakoteswari A,
Venkataraman H, et al.
Vitamin B12 status in women
of childbearing age in the UK
and its relationship with
national nutrient intake
guidelines: results from two
National Diet and Nutrition
Surveys. BMJ Open 2016;6:
e011247. doi:10.1136/
bmjopen-2016-011247
▸ Prepublication history and
additional material is




NS and AA contributed
equally.
Received 22 January 2016
Revised 22 May 2016












Objective: To assess serum B12, folate and the
associated homocysteine (Hcy) levels among women of
childbearing age in the UK and examine their association
with dietary intake in relation to the UK Recommended
Nutrient Intakes (RNIs) for B12 and folate.
Design: Cross-sectional study.
Setting: Data from two publicly available National Diet
and Nutrition Surveys (NDNS 2000/2001 and 2008/
2012) were used. These were population-based surveys
of randomly selected samples of adults which were
carried out in their households.
Participants:Women of childbearing age (aged
19–39 years), representative of the UK population. Those
who were pregnant or breastfeeding were excluded.
Outcome measures: The associations between
micronutrient intakes and blood levels of B12, folate and
Hcy were assessed by correlation and stepwise linear
regression. B12 intake was divided into quintiles and
plotted against blood B12 and Hcy concentrations to
determine the threshold of any associations.
Results: 299 women from the first NDNS cohort had
complete intake and biomarker data. The prevalence of
serum vitamin B12 (≤150 pmol/L) and serum folate
(≤10 nmol/L) deficiency and hyperhomocysteinemia
(≥12 µmol/L) was 12.4%, 6.4% and 21.2%, respectively,
despite seemingly adequate B12 intakes (median 3.8 μg/
day, 96% consumed more than the UK RNI of 1.5 μg/
day). B12 concentrations increased across all quintiles of
intake with serum levels in quintiles 4 and 5 (median
intake 4.9 and 7.1 μg/day, respectively) significantly
higher than quintile 1. However, Hcy concentrations
levelled off between quintiles 4 and 5. Comparison of
micronutrient intake between the two surveys found
that folate intake has reduced in the more recent
cohort.
Conclusions: The UK RNI for B12 intake should be
increased for women of childbearing age with intakes of
around 5–7 μg/day likely to be associated with stable
biomarker levels. B12 levels should also be measured in
women preconceptionally or in early pregnancy given the
high rates of deficiency.
INTRODUCTION
Vitamin B12 (B12), also known as cobalamin,
is a micronutrient essential for cellular
growth, differentiation and development.1
Along with folate, B12 is necessary for the
synthesis of DNA, RNA, lipids and protein,
and an essential step in this process is the
conversion of homocysteine (Hcy) to methio-
nine.2 Therefore, a deﬁciency of either B12
or folate leads to increased Hcy which can
have signiﬁcant clinical implications such as
cardiovascular disease and atherosclerosis in
adults.3 4
During pregnancy, low circulating levels of
B12 or folate have been associated with com-
plications such as neural tube defects
(NTDs),5 spontaneous abortion,6 premature
birth7 and possibly low birth weight.8
Strengths and limitations of this study
▪ Two publicly available data sets from the British
National Diet and Nutrition Surveys (NDNS) were
used to investigate the association between
dietary intake of B12 and folate and their blood
concentrations in women of childbearing age.
▪ The women sampled in the surveys were repre-
sentative of UK adults; therefore, the findings
can be generalised to the wider UK population.
▪ Information about the participants, including
demographics, dietary intakes, blood results and
anthropometry, was used for detailed analysis of
the outcomes of interest.
▪ The availability of two separate NDNS data sets
allowed comparison of micronutrient intakes
over the last 15 years in young women.
▪ Blood micronutrient concentrations were not
analysed in the more recent survey. Therefore,
the associations observed in the first survey
could not be replicated.
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Mandatory folic acid fortiﬁcation in North America has
resulted in reduction of NTD by over 40% in the last
10 years,9 but there has been a tripling of the condition
attributable to B12 deﬁciency during the same time
frame in this population.10 Maternal hyperhomocysteine-
mia has been linked to early pregnancy losses,11 pre-
eclampsia12 and small for gestational age babies.13
Although the exact mechanisms are not known, some of
these effects may be mediated by vascular compromise
to the fetus and insufﬁcient placental development
which occurs in the early embryonic period.14 As
around half of the pregnancies are unplanned, even in
developed countries,15 there is increasing attention on
optimising the nutrient status of women in the pericon-
ceptional period.
B12 deﬁciency is prevalent during pregnancy as shown
by a large systematic review recently conducted by our
group.8 We showed that the rates were in the order of
20–30% in all three trimesters across the world, with par-
ticular high rates in studies from the Indian subcontin-
ent, Eastern Mediterranean and South American
regions.16–18 A longitudinal study has shown that cobala-
min levels can decrease by around 10–20% from precon-
ception to the ﬁrst and second trimesters, respectively.19
However, there are no studies in the UK that assessed
the B12 intake or circulating levels in women of repro-
ductive age prior to conception.
The UK Department of Health (DOH) has stipulated
that the Recommended Nutrient Intake (RNI) for B12
and folate in adults is 1.5 and 200 μg per day, respectively,
with no different recommendations for women (preg-
nant or otherwise) and the elderly.20 These recommenda-
tions were published in 1991 and state that the RNI for
B12 ‘represent the level of intake considered likely to be
sufﬁcient to meet the requirements of 97.5% of the
group’.21 The evidence for this RNI is from reports in the
1970s, which estimated the average requirement to
prevent diet-related B12 deﬁciency and megaloblastic
anaemia.22–24 B12 deﬁciency in these studies was arbitrar-
ily deﬁned as <150 pmol/L without use of any functional
markers of B12 deﬁciency.
25 26 Thus, there are little con-
temporary data to support how accurately the recom-
mended intakes correlate with serum values of B12 and
functional indicators such as Hcy. The primary aim of
this study is to determine the serum B12, folate and Hcy
status of women of childbearing age in the UK and to
assess the correlation between estimated B12 intake and
blood concentrations of B12 and Hcy using the data from
two British National Diet and Nutrition Survey (NDNS)
in 2000/2001 and 2008/2012. The secondary aim is to
compare the nutritional intake between the two NDNS
cohort to provide more recent data on B12 intake.
METHODS
Subjects
We used data collected from the two British NDNS
between July 2000 and June 2001 and 2008–2012. The
surveys provide detailed quantitative assessment of nutri-
tional status and laboratory results of the participants.
The methods used in the survey have previously been
described in detail.27–29 The samples were made up of
randomly selected adults aged 19–64 years living in
private households, who were representative of the UK
adult population. Their selection was done by a multi-
stage, stratiﬁed, probability sampling with postal sectors
as ﬁrst stage units. If there were more than one adult in
the same household, one was selected randomly. Women
who were pregnant or breast feeding were excluded.
The selection of the participants included in our ana-
lysis is provided in online supplementary ﬁgures S1 and
S2. For the ﬁrst survey (2000/2001), the ﬁeldwork was
carried out over a 12-month period, with respondents
being surveyed over four 3-month periods to account for
seasonal variations in nutritional behaviour and content.
Out of 3704 potentially eligible adults identiﬁed for the
study, 299 women between 19 and 39 years of age
(known as women of ‘childbearing age’ for the purpose
of our analysis) with complete dietary and biomarker
information were included in the ﬁnal analysis. In an
independent study,30 no evidence of was found of non-
response bias in this NDNS data.
The second survey (2008/2012) consisted of 2424
adults of whom 395 were women of childbearing age.
Unfortunately, blood samples were only obtained from
157 of these women (ie, 39.7% of all females aged 19–
39 years). The main reasons for this low return of blood
samples were ‘no nurse visit’, ‘participant refused’ and
‘blood sample inapplicable’. Owing to the potential bias
from a sample of women not representative of the larger
NDNS cohort, we only included and compared the
micronutrient intakes from the two surveys to assess the
secular trend.
Assessment of dietary intake
This has been described in detail elsewhere.27 Brieﬂy,
dietary assessment for each participant was done by a
two-stage process: (1) two face-to-face interviews using
computer-assisted personal interviewing methods, and
(2) a 7-day dietary record using weighed food diaries.
Each participant was provided with a set of Soehnle
Quanta digital food scales and two recording diaries
(for use at home and outside). Additional information
was obtained about the use of medicines, vitamin and
mineral supplements. Information provided in the food
diaries was later used to determine nutrient intakes by
linking to the Food Standards Agency nutrient database,
which holds details for 56 nutrients for each of 6000
food codes.27
Laboratory methods
Venous blood samples were taken at the non-fasting
state by trained phlebotomists in participants’ homes.
Serum folate and B12 measurements were performed on
the Abbott IMx semiautomated analyser, which uses
microparticle enzyme immunoassay (MEIA) technology
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(z). Quality control consisted of an internal pooling of
serum samples with each run for use as a drift control,
and an external quality assessment by the UK National
External Quality Assessment Service (NEQAS). Outlying
results were deﬁned as serum B12 level >1000 pmol/L
and serum folate >60 nmol/L and were excluded.
Plasma Hcy measurements were performed by the
Abbott IMx assay on the IMx analyser. Quality control
consisted of participation in an international external
quality assessment scheme based in Denmark31 and by
the manufacturer’s QV samples.
Statistical analysis
Statistical analysis was performed with SPSS V.22.0 (IBM
SPSS Statistics for Windows, Version 22.0 (program).
Armonk, NY: IBM Corp, Released 2013). For continuous
variables (eg, mean B12/folate intakes and levels
between RNI threshold groups), the Student’s t-test and
for categorical variables (eg, B12 and folate deﬁciency
rates), the χ2 test for independence or the Fisher’s exact
test was used. Stepwise multiple linear regression analysis
with each of serum B12, folate and plasma Hcy as the
dependent variable was done, with predictors entered or
removed following the criteria: probability of F to enter
≤0.050, probability of F to remove ≥0.100. The regres-
sion models included the following covariates: age, body
mass index (BMI), total cholesterol:high-density lipopro-
tein (TC:HDL) ratio, alcohol intake, smoking status, oral
contraceptive use, vegan/vegetarian, serum folate and
where appropriate daily folate intake (with supple-
ments), daily B12 intake (with supplements) and serum
B12 levels. Race was not included in the analysis as the
majority of the participants (95%) were white. To deter-
mine the trend of B12 and Hcy across the spectrum of
B12 intakes, we divided the cohort into quintiles of B12
intake. One-way analysis of variance (ANOVA) with
Tukey’s post hoc test was applied to compare the serum
levels against the lowest quintile. Logistic regression was
then done for incremental B12 intake thresholds of
0.25 μg to determine predictors of B12 deﬁciency and
hyperhomocysteinemia. In order to estimate the preva-
lence of inadequate B12 intake in our population and
observe how this was related to abnormal biomarker
levels, we used the Estimated Average Requirement
(EAR) cut-point method.32 The EAR was calculated as
1.25 μg/day based on a coefﬁcient of variation of 10%
below the UK RNI.25
The deﬁnitions for micronutrient deﬁciencies were as
follows: serum B12≤150 pmol/L,33 serum folate
≤10 nmol/L34 and red cell folate <350 nmol/L.34 The
upper limit of normal for plasma Hcy in non-pregnant
adults aged 15–65 has been variably deﬁned as
12 µmol/L in non-pregnant adults with folic acid fortiﬁ-
cation or supplementation35 and 15 µmol/L in those
without fortiﬁcation or supplementation, which applies
to our population. However, Hcy levels above
10.7 µmol/L in women during preconception has been
associated with pre-eclampsia, prematurity and very low
birthweight infants if they become pregnant.12 In add-
ition, other experts recommend <12 µmol/L for all
adults.36 Therefore, we have presented results for 12 and
15 µmol/L and stated these clearly throughout.
RESULTS
From the NDNS 2000/01 cohort, 299 women of child-
bearing age had complete dietary and serum micronu-
trient level results. The demographics and clinical
characteristics of these women are shown in table 1.
Their mean age was 31.6 years and BMI 25.3 kg/m2. To
determine how the B12/folate intakes women of child-
bearing age compared with older women from the same
NDNS survey, we analysed these parameters in women
aged 40–64 years. The younger women consumed sig-
niﬁcantly less B12 and folate (median 3.83 vs 5.16 and
237 vs 279 μg/day, respectively, p<0.001 for both) and
consisted of more vegetarians/vegans (8.7% vs 4.2%,
p<0.05) and less B12 supplement users (10.4% vs 16.2%,
p<0.05). Folic acid supplement use was the same (data
not shown).
The blood levels of B12, folate and Hcy in women of
childbearing age and according to categories of UK RNI
for B12 intake (adequate/inadequate) are given in table 2.
The median serum B12 concentration was 241 pmol/L.
Overall, 12% of women were B12 deﬁcient (<150 pmol/L),
despite the median B12 intake of the deﬁcient women
being nearly two times the UK RNI (2.96 μg/day; data
not shown). In total, 3.7% of the surveyed population
had B12<150 pmol/L and Hcy>12 µmol/L, with a signiﬁ-
cantly higher proportion having the combination of
Table 1 Demographics and B12 and folate intakes of
women of childbearing age (NDNS 2000/2001 cohort)
Female 19–39 years All subjects (n=299)
Age (years) 31.6±5.7
BMI (kg/m2) 25.4±5.2
Obesity, n (%) 46 (15.7)
Current smokers, n (%) 117 (39.1)
Regular alcohol drinkers, n (%) 267 (89.3)






Vegetarians, n (%) 26 (8.7)
B12 supplement users, n (%) 31 (10.4)




Folic acid supplement users, n (%) 32 (10.7)
Folate intake with supplements
(μg/day)
237 (177, 315)
Continuous variables are mean±SD or median (IQR).
Categorical variables are n (%).
BMI, body mass index; NDNS, National Diet and Nutrition
Surveys.
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abnormalities when their estimated was lower than the
UK RNI (9.1% vs 3.5%, p=0.001). There is evidence that
B12 levels <258 pmol/L may be indicative of B12 deﬁ-
ciency in certain individuals with concomitant elevation
of Hcy and methylmalonic acid (MMA).37 In total,
44.0% of women had B12 levels in this borderline range
of 150–258 pmol/L. In this subgroup, mean Hcy levels
were signiﬁcantly higher than the group with
B12>258 pmol/L (10.4 vs 9.2 µmol/L, p=0.02) despite
similar folate levels (21.4 vs 22.0 nmol/L, p=NS).
The plasma Hcy concentrations were higher in the
lower intake group (11.9 vs 9.2 µmol/L, p<0.05)
although hyperhomocysteinemia (Hcy>12 µmol/L) was
present in 20% of women with apparently adequate B12
intake (table 2). Serum and red cell folate deﬁciency
rates were 6.1% and 4.4%, respectively, in the whole
population. There were no differences in the folate deﬁ-
ciency rates between above and below the UK RNI B12
intake groups. In total, 34.4% of the women were taking
the oral contraceptives and their B12 values were lower
than those who were not (median 211.5 vs 267.5 pmol/
L, p<0.001).
In total, 8.7% of women in the whole cohort were
vegetarian or vegan and their median dietary intake of
B12 was non-signiﬁcantly lower than non-vegetarians
(2.95 vs 3.87 μg/day), while folate consumption in the
former group was higher (see online supplementary
table S1). Vegetarians had lower serum B12 concentra-
tions (median 192 vs 248 pmol/L, p<0.01) but their
folate or Hcy concentrations did not vary signiﬁcantly.
Predictors of B12, folate and Hcy
There was a positive correlation between serum B12
values and daily B12 intake (Pearson’s r=0.27, p<0.001)
(ﬁgure 1). Simple linear regression analyses of the pre-
dictors of B12, folate and Hcy are shown in table 3. After
adjusting for the likely confounders, daily B12 and folic
acid intakes were positive predictors of serum B12
(β=0.28, p<0.001) and serum folate (β=0.33, p<0.001),
respectively. Along with age, serum B12, serum folate
and B12 intake were independent predictors of Hcy,
though it would appear that serum folate is strongest
based on the value of the β coefﬁcient (table 3).
Relationship between B12 intake and associated biomarkers
In total, 5 out of 299 (1.7%) women consumed below
the EAR of 1.25 μg/day, but none of them had B12 levels
<150 pmol/L. Conversely, in the 98.3% of women with
‘adequate’ EAR category for B12 consumption, 12.2% of
them had serum levels below 150 pmol/L.
In order to determine the trend of blood B12 and Hcy
concentrations with increasing intakes of B12, we divided
the cohort in quintiles of B12 intake. The median levels
Table 2 Comparison of B12, folate and plasma homocysteine concentrations in women according to the UK RNI for vitamin
B12 intake
Female 19–39 years All subjects
UK RNI (μg/day)
p value*<1.5 ≥1.5
Number (%) 299 (100) 11 (3.7) 288 (96.3)
B12 intake, diet only (μg/day) 3.82 (2.75, 5.02)† 1.29 (0.64, 1.46) 3.86 (2.86, 5.09) <0.001
B12 intake, diet+supplements (μg/day) 3.83 (2.82, 5.20) 1.29 (0.98, 1.46) 3.92 (2.88, 5.32) <0.001
Serum B12 (pmol/L) 241 (188, 324) 169 (153, 256) 244 (189, 325) 0.05
B12 deficiency (<150 pmol/L), n (%) 36 (12.0) 2 (18.2) 34 (11.8) NS
Serum folate (nmol/L) 19.5 (14.1, 26.7) 14.3 (13.6, 21.3) 19.7 (14.2, 27.0) NS
Serum folate deficiency (<10 nmol/L), n (%) 18 (6.1) 0 (0) 18 (6.3) NS
Red cell folate (nmol/L) 584 (473.9, 750.6) 460 (372, 739) 585 (478, 751) NS
Red cell folate deficiency (<350 nmol/L), n (%) 13 (4.4) 2 (18.2) 11 (3.8) NS
Hcy (μmol/L) 9.4 (9.1, 9.8) 11.9 (9.6, 14.3) 9.2 (7.8, 11.4) <0.05
High Hcy (>12 μmol/L), n (%) 62 (21.2) 5 (50) 57 (20.1) <0.05
High Hcy (>15 μmol/L), n (%) 24 (8.2) 2 (20) 22 (7.8) NS
*Comparison between lower and higher B12 intake groups. For categorical variables, Student’s t-test was used (after log transformation); for
continuous variables, Fisher’s exact test was used.
†Median, 25–75th centile in parentheses (all such values).
Hcy, homocysteine; NS, not significant; UK RNI, UK Recommended Nutrient Intake.
Figure 1 Correlation between daily B12 intake and serum
B12 values. §Log transformed for statistical comparisons.
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in each quintile and biomarker values are represented
in ﬁgures 2A, B. Women in quintiles 4 and 5 (median
intake 4.9 and 7.1 μg/day, respectively) had signiﬁcantly
higher mean B12 and lower mean Hcy concentrations
than quintile 1 (291 and 322 vs 229 pmol/L; 9.0 and 9.0
vs 11.4 µmol/L, respectively). Additionally, the Hcy
levels appear to level off between quintiles 4 and 5, sug-
gesting that increasing intakes above 5 μg/day is unlikely
to provide higher B12 at the tissue level (ﬁgure 2B). To
conﬁrm this, we performed logistic regression to deter-
mine the intake threshold at which the odds of hyperho-
mocysteinemia would reduce signiﬁcantly after
correcting for confounders. Using 0.25 μg increments, a
threshold of 4.75 μg/day signiﬁcantly reduced the odds
of Hcy>12 µmol/L (adjusted OR (AOR) 0.35, 95% CI
0.14 to 0.88). When serum B12 was added to the model,
the signiﬁcance was lost, suggesting that the inﬂuence of
dietary B12 intake on circulating Hcy is mediated
through serum B12 values in a folate-replete population
(data not shown).
Micronutrient intake: comparisons between NDNS 2000/
2001 and 2008/2012 data
Comparison of the mean nutrient intake among young
women between the two surveys is shown in table 4. The
proportion of women consuming below the UK RNI for
folate increased in the more recent survey (44% vs 33%,
p<0.01) and median intake levels fell by 14% (206 vs
235 pmol/L, p<0.001). There were no signiﬁcant differ-
ences in the B12 intake values.
DISCUSSION
Our study shows contemporary data of B12 and folate
intakes and serum levels in population-based nutritional
surveys involving women of childbearing age, who are
representative of the UK population. The key ﬁndings
are that, despite an apparent adequate daily intake of
B12, a high proportion of women have B12 deﬁciency
and hyperhomocysteinemia.
Optimum B12 intake and biomarker levels
Our data showed positive correlation between B12 intake
and blood levels with a trend of increasing B12 concen-
tration even in intakes up to 7 μg/day, although the cor-
responding reductions in Hcy levels level off around the
intake of 5–7 μg/day. Additionally, the consumption of
around 4.75 μg/day was independently associated with a
decrease in the odds of hyperhomocysteinemia. Our
ﬁndings are supportive of the dose–response relation-
ship between intake and blood levels of B12 found previ-
ously, which showed doubling B12 intakes would increase
B12 concentrations by around 10%.
38
A daily intake of 4–10 μg has been suggested by other
studies to stabilise levels of B12, Hcy and the associated
MMA in adults,39 40 but more evidence is needed before
extrapolating these ﬁgures to women of childbearing
age due to the different requirements and implications
should they become pregnant. In a randomised con-
trolled trial where all subjects consumed 8.6 μg/day of
B12, pregnant women had higher holotranscobalamin
(holoTC):total B12 ratios than non-pregnant, non-
lactating controls, suggesting that such high intakes were
required to provide sufﬁcient supply to the developing
fetus.41 More research is required to decide on the
upper limit of B12 intake in women before and during
pregnancy, as higher B12 intake in the third trimester
was positively associated with offspring birth weight in
high-BMI women (who are already at high risk of having
macrosomic babies), although circulating B12 levels were
not reported here.42 There is also no consistent evi-
dence that increased B12 intake or supplementation is
associated with reduction in the prevalence of subclin-
ical B12 deﬁciency in adults (particularly neurocognitive
decline in the elderly).43 44 Therefore, until the
Table 3 Multiple linear regression analysis of predictors of serum B12, folate and homocysteine
Variables
Serum B12* Serum folate Homocysteine*
β coefficient p Value β coefficient p Value β coefficient p Value
Age – NS – NS 0.18 0.001
BMI – NS – NS – NS
Smoking –0.12 <0.05 – NS – NS
Alcohol – NS – NS – NS
Oral contraceptive use −0.29 <0.001 0.11 <0.05 – NS
TC:HDL ratio* – NS – NS – NS
Vegetarian or vegan diet −0.18 <0.01 – NS – NS
B12 supplement use – NS Not included NA – NS
Daily B12 intake* 0.28 <0.001 Not included NA –0.16 0.001
Folic acid supplement use Not included NA 0.18 <0.01 – NS
Daily folate intake* Not included NA 0.33 <0.001 – NS
Serum B12* – NS −0.20 <0.001
Serum folate* – NS −0.35 <0.001
*Log transformed for statistical comparison.
–, Tested but not significant in the model;
BMI, body mass index; NA, not applicable; NS, not significant; TC:HDL, total cholesterol:high-density lipoprotein ratio.
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availability of further studies, our data call for revision of
the UK RNI (and EAR) for B12 to be at least in line with
the current European recommendations (4.5 μg/day).24
The estimated B12 intake in preconceptional or women
in early pregnancy and speciﬁcally its relationship with
serum levels has not been widely studied. In developing
countries, over 50% of women of reproductive age do
not meet the RNIs for B12
45 46 and separate surveys from
three developing countries (Turkey, Iran and China)
found B12 deﬁciency rates of 21–23%.
47–49 An Australian
study on young females found a similar rate to ours
(11.4%), albeit using a lower threshold of 120 pmol/L.50
As the B12 levels fall by around 10% from preconception
to early pregnancy,19 if we extrapolate our ﬁndings, the
proportion of pregnant women with B12 levels below
150 pmol/L is likely to be much higher. More than a
third of vegetarian/vegan women in our study had B12
deﬁciency, which was in keeping with studies from other
UK adult population51 and elsewhere.52 Thus our ﬁnd-
ings highlight the need for speciﬁc advice for the vegetar-
ian/vegan population about potential sources of B12, as
well as recommending them to have their B12 levels
checked (and corrected) if they are planning pregnancy.
Folate intake
Our study shows that consumption of dietary folate has
fallen by around 14% in the 10 years between the two
surveys and nearly 50% of women are now consuming
below the UK RNI. The Scientiﬁc Advisory Committee
on Nutrition within the UK Food Standards Agency has
recommended mandatory folic acid fortiﬁcation of food
products to the UK DOH,53 which, if implemented,
would increase folate intake and consequently serum
levels in the population as it did in the USA.54 However,
if mandatory fortiﬁcation does occur, it is possible that
improving folate levels can reduce B12 levels due to
usage of the available B12.
55 In addition, B12 deﬁciency
is the strongest driver of Hcy in a folate-replete popula-
tion.56 Therefore fortiﬁcation of food products with B12
together with folate should be considered if there is to
be a policy change in the UK or, as a minimum, B12 sup-
plements recommended for women in the peri-
conceptional period, especially if they are at high risk of
deﬁciency.
The strengths of our study are that this is the ﬁrst
study of its kind from the UK to evaluate B12 and folate
Figure 2 Relationship between B12 intake in quintiles and
(A) mean serum B12 and (B) mean plasma homocysteine
concentrations. Mean±SEM values are plotted against the
median B12 intake in each quintile. One-way analysis of
variance (ANOVA) test used to compare the means between
the quintiles (after log transformation) and Tukey’s post hoc
analysis done. Mean biomarker levels differed as compared
with quintile 1 as follows: *p<0.05; **p<0.01; ***p<0.001.
Table 4 Comparison between folic acid and B12 intakes between the NDNS 2000/2001 and 2008/2011 cohorts
Female 19–39 years NDNS 2000/2001 cohort NDNS 2008/2011 cohort
Number 299 395
Folic acid supplement users, n (%) 32 (10.7) 12 (3.0)***,†
Folate intake, diet only (μg/day) 234.9 (175.7, 302.7)‡ 205.8 (162.3, 261.2)***
n (%) consuming below UK RNI of folate 99 (33.1) 173 (43.8)**
B12 supplement users, n (%) 31 (10.4) 33 (8.4)
B12 intake, diet only (μg/day) 3.82 (2.75, 5.01) 3.78 (2.64, 4.84)
n (%) consuming below UK RNI of B12 11 (3.7) 24 (6.1)
Significance: **p<0.01; ***p<0.001
†p Values from independent-samples t-test for continuous variables (after log transformation) or χ2 test for categorical variables.
‡Median, 25–75th centile in parentheses (all such values).
UK RNI, UK Recommended Nutrient Intake; NDNS, National Diet and Nutrition Survey.
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among women in the preconceptional stage. Extensive
data on these women including anthropometry, bio-
chemical markers and dietary information allowed com-
parison of intake and serum levels adjusted for possible
confounders. There were three important limitations of
this data set: (1) lack of sufﬁcient biochemical data in
the second survey, (2) lack of data on other biomarkers
such as holoTC or MMA and (3) lack of haematological
and clinical information relevant to the effects of B12.
Since we were able to compare the nutrient intakes
between the two cohorts, which was predictive of serum
levels in the earlier survey, we believe that the availability
of serum B12 in the latter cohort may not necessarily
change the ﬁndings. Hcy is a readily available marker
in clinical practice as opposed to holoTC and MMA.
Therefore, our ﬁndings are applicable to wider clin-
ical practice. Any future prospective studies involving
preconceptional or pregnant women should include
more clinical information as well as these biomarkers
for a better evaluation of B12 status. In conclusion, our
study supports revision of the UK RNI to at least
match the European recommendations and also calls
for assessing maternal B12 status in preconception or
early pregnancy.
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